Fluoroquinolone-Resistant Escherichia coli Sequence Type 131 Isolates Causing Bloodstream Infections in a Canadian Region with a Centralized Laboratory System: Rapid Emergence of the H30-Rx Sublineage
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fluoroquinolone-Resistant Escherichia coli Sequence Type 131 Isolates Causing Bloodstream Infections in a Canadian Region with a Centralized Laboratory System: Rapid Emergence of the H30-Rx Sublineage
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 58, Issue 5, Pages 2699-2703
Publisher
American Society for Microbiology
Online
2014-02-25
DOI
10.1128/aac.00119-14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Fluoroquinolone Resistance, Virulence Genes, and IncF Plasmids with Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type 131 (ST131) and ST405 Clonal Groups
- (2013) Yasufumi Matsumura et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Epidemiology of Escherichia coli Sequence Type 131 and Its H30 and H30-Rx Subclones among Extended-Spectrum-β-Lactamase-Positive and -Negative E. coli Clinical Isolates from the Chicago Region, 2007 to 2010
- (2013) Ritu Banerjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans
- (2013) Aylin Colpan et al. CLINICAL INFECTIOUS DISEASES
- Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli
- (2013) James R. Johnson et al. JOURNAL OF INFECTIOUS DISEASES
- The Epidemic of Extended-Spectrum- -Lactamase-Producing Escherichia coli ST131 Is Driven by a Single Highly Pathogenic Subclone, H30-Rx
- (2013) L. B. Price et al. mBio
- The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms
- (2012) Akke K. Van der Bij et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Extraintestinal pathogenicEscherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment
- (2012) Johann DD Pitout Expert Review of Anti-Infective Therapy
- Genetic Features ofblaNDM-1-Positive Enterobacteriaceae
- (2011) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Epidemiology over an 11-Year Period (2000 to 2010) of Extended-Spectrum -Lactamase-Producing Escherichia coli Causing Bacteremia in a Centralized Canadian Region
- (2011) G. Peirano et al. JOURNAL OF CLINICAL MICROBIOLOGY
- High Prevalence of ST131 Isolates Producing CTX-M-15 and CTX-M-14 among Extended-Spectrum- -Lactamase-Producing Escherichia coli Isolates from Canada
- (2010) G. Peirano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Escherichia coliSequence Type ST131 as the Major Cause of Serious Multidrug‐ResistantE. coliInfections in the United States
- (2010) James R. Johnson et al. CLINICAL INFECTIOUS DISEASES
- Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4
- (2010) Gisele Peirano et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The epidemiology of urinary tract infection
- (2010) Betsy Foxman Nature Reviews Urology
- Molecular Characteristics of Extended-Spectrum- -Lactamase-Producing Escherichia coli Isolates Causing Bacteremia in the Calgary Health Region from 2000 to 2007: Emergence of Clone ST131 as a Cause of Community-Acquired Infections
- (2009) J. D. D. Pitout et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Detection of AmpC β-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory
- (2009) J.D.D. Pitout et al. CLINICAL MICROBIOLOGY AND INFECTION
- Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains
- (2009) O. Clermont et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prevalence of Plasmid-Mediated Quinolone Resistance Determinants over a 9-Year Period
- (2008) H. B. Kim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Changes in aac(6')-Ib-cr Prevalence and Fluoroquinolone Resistance in Nosocomial Isolates of Escherichia coli Collected from 1991 through 2005
- (2008) G. Warburg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Plasmid-Mediated qepA Gene among Escherichia coli Clinical Isolates from Japan
- (2008) K. Yamane et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region
- (2008) K.B. Laupland et al. CLINICAL MICROBIOLOGY AND INFECTION
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
- (2008) Johann DD Pitout et al. LANCET INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More